Societal CDMO Inc
F:RAH

Watchlist Manager
Societal CDMO Inc Logo
Societal CDMO Inc
F:RAH
Watchlist
Price: 1.58 EUR Market Closed
Market Cap: 165.5m EUR
Have any thoughts about
Societal CDMO Inc?
Write Note

Wall Street
Price Targets

RAH Price Targets Summary
Societal CDMO Inc

There are no price targets for RAH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Societal CDMO Inc Competitors:
Price Targets
3692
Hansoh Pharmaceutical Group Company Ltd
35% Upside
MYX
Mayne Pharma Group Ltd
22% Upside
002422
Sichuan Kelun Pharmaceutical Co Ltd
26% Upside
600062
China Resources Double-Crane Pharmaceutical Co Ltd
22% Upside
AXSM
Axsome Therapeutics Inc
40% Upside
KILITCH
Kilitch Drugs (India) Ltd
56% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
41% Upside
NATCOPHARM
Natco Pharma Ltd
8% Downside

Revenue
Forecast

Revenue Estimate
Societal CDMO Inc

For the last 8 years the compound annual growth rate for Societal CDMO Inc's revenue is 8%. The projected CAGR for the next 3 years is 6%.

8%
Past Growth
6%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Societal CDMO Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Societal CDMO Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAH's stock price target?
Not Available

RAH doesn't have any price targets made by Wall Street professionals.

What is Societal CDMO Inc's Revenue forecast?
Projected CAGR
6%

For the last 8 years the compound annual growth rate for Societal CDMO Inc's revenue is 8%. The projected CAGR for the next 3 years is 6%.

Back to Top